TOP NEWS: AstraZeneca Discontinues Alzheimer's Disease Treatment Trial
LONDON (Alliance News) - AstraZeneca PLC said Tuesday it has decided to discontinue trials of a new drug for Alzheimer's disease as the treatment is unlikely to meet its primary test UK listed Read More